NCT00261820View on ClinicalTrials.gov

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 2005

Conditions
Graft RejectionKidney FailureKidney Transplantation
Interventions
DRUG

tacrolimus

DRUG

mycophenolate mofetil

DRUG

methylprednisolone

DRUG

prednisolone

DRUG

sirolimus

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00261820 - Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients | Biotech Hunter | Biotech Hunter